Ethic Inc. Has $2 Million Stock Holdings in Cardinal Health, Inc. $CAH

Ethic Inc. trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 2.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,942 shares of the company’s stock after selling 357 shares during the period. Ethic Inc.’s holdings in Cardinal Health were worth $1,996,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Atlantic Edge Private Wealth Management LLC increased its stake in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares in the last quarter. Greykasell Wealth Strategies Inc. bought a new stake in Cardinal Health during the 1st quarter worth approximately $26,000. GW&K Investment Management LLC increased its stake in Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares in the last quarter. Harbor Asset Planning Inc. bought a new stake in Cardinal Health during the 2nd quarter worth approximately $49,000. Finally, Pittenger & Anderson Inc. increased its stake in Cardinal Health by 366.7% during the 2nd quarter. Pittenger & Anderson Inc. now owns 350 shares of the company’s stock worth $59,000 after purchasing an additional 275 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Up 1.7%

NYSE CAH opened at $161.83 on Friday. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44. The company has a market capitalization of $38.45 billion, a PE ratio of 25.09, a price-to-earnings-growth ratio of 1.37 and a beta of 0.71. The firm’s 50 day moving average is $152.75 and its 200-day moving average is $152.88.

Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same period last year, the business earned $1.84 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were paid a $0.5107 dividend. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Insider Activity

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Leerink Partners increased their target price on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Robert W. Baird raised their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Friday. Finally, Evercore ISI lowered their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $166.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.